UniProt ID | BASP1_HUMAN | |
---|---|---|
UniProt AC | P80723 | |
Protein Name | Brain acid soluble protein 1 | |
Gene Name | BASP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 227 | |
Subcellular Localization |
Cell membrane Lipid-anchor. Cell projection, growth cone. Associated with the membranes of growth cones that form the tips of elongating axons. |
|
Protein Description | ||
Protein Sequence | MGGKLSKKKKGYNVNDEKAKEKDKKAEGAATEEEGTPKESEPQAAAEPAEAKEGKEKPDQDAEGKAEEKEGEKDAAAAKEEAPKAEPEKTEGAAEAKAEPPKAPEQEQAAPGPAAGGEAPKAAEAAAAPAESAAPAAGEEPSKEEGEPKKTEAPAAPAAQETKSDGAPASDSKPGSSEAAPSSKETPAATEAPSSTPKAQGPAASAEEPKPVEAPAANSDQTVTVKE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | N-myristoyl glycine | ------MGGKLSKKK ------CCCCCCCCC | 41.78 | - | |
2 | Myristoylation | ------MGGKLSKKK ------CCCCCCCCC | 41.78 | 9310187 | |
10 | Ubiquitination | GKLSKKKKGYNVNDE CCCCCCCCCCCCCHH | 75.42 | 33845483 | |
12 | Phosphorylation | LSKKKKGYNVNDEKA CCCCCCCCCCCHHHH | 25.47 | - | |
18 | Succinylation | GYNVNDEKAKEKDKK CCCCCHHHHHHHHHH | 68.56 | 23954790 | |
18 | Acetylation | GYNVNDEKAKEKDKK CCCCCHHHHHHHHHH | 68.56 | 27452117 | |
18 | 2-Hydroxyisobutyrylation | GYNVNDEKAKEKDKK CCCCCHHHHHHHHHH | 68.56 | - | |
18 | Ubiquitination | GYNVNDEKAKEKDKK CCCCCHHHHHHHHHH | 68.56 | 21963094 | |
20 | Ubiquitination | NVNDEKAKEKDKKAE CCCHHHHHHHHHHHH | 76.10 | 22817900 | |
22 | Ubiquitination | NDEKAKEKDKKAEGA CHHHHHHHHHHHHHC | 74.31 | 22817900 | |
24 | Ubiquitination | EKAKEKDKKAEGAAT HHHHHHHHHHHHCCC | 66.02 | 21963094 | |
25 | Sumoylation | KAKEKDKKAEGAATE HHHHHHHHHHHCCCC | 62.90 | 28112733 | |
25 | Ubiquitination | KAKEKDKKAEGAATE HHHHHHHHHHHCCCC | 62.90 | 33845483 | |
31 | Phosphorylation | KKAEGAATEEEGTPK HHHHHCCCCCCCCCC | 43.31 | 22167270 | |
36 | Phosphorylation | AATEEEGTPKESEPQ CCCCCCCCCCCCCCC | 34.17 | 22167270 | |
38 | Acetylation | TEEEGTPKESEPQAA CCCCCCCCCCCCCHH | 73.95 | 26051181 | |
38 | Ubiquitination | TEEEGTPKESEPQAA CCCCCCCCCCCCCHH | 73.95 | 21963094 | |
40 | Phosphorylation | EEGTPKESEPQAAAE CCCCCCCCCCCHHHC | 61.78 | 25159151 | |
52 | Ubiquitination | AAEPAEAKEGKEKPD HHCHHHHHCCCCCCC | 59.51 | 21963094 | |
52 | Acetylation | AAEPAEAKEGKEKPD HHCHHHHHCCCCCCC | 59.51 | 26051181 | |
55 | Ubiquitination | PAEAKEGKEKPDQDA HHHHHCCCCCCCCCC | 64.75 | 22817900 | |
57 | Ubiquitination | EAKEGKEKPDQDAEG HHHCCCCCCCCCCCC | 58.33 | 32142685 | |
65 | Ubiquitination | PDQDAEGKAEEKEGE CCCCCCCHHHHHHHH | 44.10 | 33845483 | |
69 | Ubiquitination | AEGKAEEKEGEKDAA CCCHHHHHHHHHHHH | 63.63 | 30230243 | |
73 | Succinylation | AEEKEGEKDAAAAKE HHHHHHHHHHHHHHH | 64.62 | 23954790 | |
73 | Ubiquitination | AEEKEGEKDAAAAKE HHHHHHHHHHHHHHH | 64.62 | 33845483 | |
79 | Ubiquitination | EKDAAAAKEEAPKAE HHHHHHHHHHCCCCC | 51.89 | 21963094 | |
79 | Succinylation | EKDAAAAKEEAPKAE HHHHHHHHHHCCCCC | 51.89 | 23954790 | |
84 | Ubiquitination | AAKEEAPKAEPEKTE HHHHHCCCCCCCCCC | 72.87 | 22817900 | |
84 | Acetylation | AAKEEAPKAEPEKTE HHHHHCCCCCCCCCC | 72.87 | 26051181 | |
84 | Succinylation | AAKEEAPKAEPEKTE HHHHHCCCCCCCCCC | 72.87 | 23954790 | |
84 | Sumoylation | AAKEEAPKAEPEKTE HHHHHCCCCCCCCCC | 72.87 | 28112733 | |
89 | Ubiquitination | APKAEPEKTEGAAEA CCCCCCCCCCCHHHH | 63.69 | 21963094 | |
89 | Acetylation | APKAEPEKTEGAAEA CCCCCCCCCCCHHHH | 63.69 | 26051181 | |
90 | Phosphorylation | PKAEPEKTEGAAEAK CCCCCCCCCCHHHHH | 37.68 | 21601212 | |
97 | Ubiquitination | TEGAAEAKAEPPKAP CCCHHHHHCCCCCCC | 44.80 | 21963094 | |
97 | Acetylation | TEGAAEAKAEPPKAP CCCHHHHHCCCCCCC | 44.80 | 26051181 | |
97 | Sumoylation | TEGAAEAKAEPPKAP CCCHHHHHCCCCCCC | 44.80 | 28112733 | |
102 | Ubiquitination | EAKAEPPKAPEQEQA HHHCCCCCCCHHHHC | 83.64 | 22817900 | |
102 | Acetylation | EAKAEPPKAPEQEQA HHHCCCCCCCHHHHC | 83.64 | 26051181 | |
121 | Ubiquitination | AAGGEAPKAAEAAAA CCCCCCCHHHHHHCC | 68.24 | 33845483 | |
132 | Phosphorylation | AAAAPAESAAPAAGE HHCCCHHHCCCCCCC | 31.66 | 23663014 | |
142 | Phosphorylation | PAAGEEPSKEEGEPK CCCCCCCCCCCCCCC | 56.85 | 25159151 | |
143 | Ubiquitination | AAGEEPSKEEGEPKK CCCCCCCCCCCCCCC | 71.19 | 21963094 | |
143 | Succinylation | AAGEEPSKEEGEPKK CCCCCCCCCCCCCCC | 71.19 | 23954790 | |
143 | Sumoylation | AAGEEPSKEEGEPKK CCCCCCCCCCCCCCC | 71.19 | - | |
143 | Acetylation | AAGEEPSKEEGEPKK CCCCCCCCCCCCCCC | 71.19 | 26051181 | |
149 | Ubiquitination | SKEEGEPKKTEAPAA CCCCCCCCCCCCCCC | 68.94 | 23503661 | |
150 | Ubiquitination | KEEGEPKKTEAPAAP CCCCCCCCCCCCCCC | 63.41 | 33845483 | |
150 | Acetylation | KEEGEPKKTEAPAAP CCCCCCCCCCCCCCC | 63.41 | 26051181 | |
151 | Phosphorylation | EEGEPKKTEAPAAPA CCCCCCCCCCCCCCC | 43.43 | 23403867 | |
151 | O-linked_Glycosylation | EEGEPKKTEAPAAPA CCCCCCCCCCCCCCC | 43.43 | 28657654 | |
162 | Phosphorylation | AAPAAQETKSDGAPA CCCCHHHHCCCCCCC | 24.62 | 23927012 | |
163 | Ubiquitination | APAAQETKSDGAPAS CCCHHHHCCCCCCCC | 45.88 | 21963094 | |
163 | Sumoylation | APAAQETKSDGAPAS CCCHHHHCCCCCCCC | 45.88 | 25114211 | |
163 | Acetylation | APAAQETKSDGAPAS CCCHHHHCCCCCCCC | 45.88 | 26051181 | |
164 | Phosphorylation | PAAQETKSDGAPASD CCHHHHCCCCCCCCC | 49.01 | 22167270 | |
170 | Phosphorylation | KSDGAPASDSKPGSS CCCCCCCCCCCCCCC | 41.16 | 22167270 | |
172 | Phosphorylation | DGAPASDSKPGSSEA CCCCCCCCCCCCCCC | 37.95 | 23927012 | |
173 | Acetylation | GAPASDSKPGSSEAA CCCCCCCCCCCCCCC | 59.39 | 26051181 | |
173 | Ubiquitination | GAPASDSKPGSSEAA CCCCCCCCCCCCCCC | 59.39 | 21963094 | |
176 | Phosphorylation | ASDSKPGSSEAAPSS CCCCCCCCCCCCCCC | 33.27 | 25159151 | |
177 | Phosphorylation | SDSKPGSSEAAPSSK CCCCCCCCCCCCCCC | 36.85 | 23927012 | |
182 | Phosphorylation | GSSEAAPSSKETPAA CCCCCCCCCCCCCCC | 49.68 | 23927012 | |
183 | Phosphorylation | SSEAAPSSKETPAAT CCCCCCCCCCCCCCC | 33.19 | 25159151 | |
184 | Acetylation | SEAAPSSKETPAATE CCCCCCCCCCCCCCC | 70.69 | 26051181 | |
184 | Ubiquitination | SEAAPSSKETPAATE CCCCCCCCCCCCCCC | 70.69 | 21963094 | |
186 | Phosphorylation | AAPSSKETPAATEAP CCCCCCCCCCCCCCC | 23.20 | 25159151 | |
190 | O-linked_Glycosylation | SKETPAATEAPSSTP CCCCCCCCCCCCCCC | 34.48 | 28657654 | |
190 | Phosphorylation | SKETPAATEAPSSTP CCCCCCCCCCCCCCC | 34.48 | 21712546 | |
194 | Phosphorylation | PAATEAPSSTPKAQG CCCCCCCCCCCCCCC | 54.62 | 22167270 | |
195 | Phosphorylation | AATEAPSSTPKAQGP CCCCCCCCCCCCCCC | 47.90 | 22167270 | |
196 | Phosphorylation | ATEAPSSTPKAQGPA CCCCCCCCCCCCCCC | 32.90 | 19664994 | |
198 | Ubiquitination | EAPSSTPKAQGPAAS CCCCCCCCCCCCCCC | 54.13 | 21963094 | |
205 | Phosphorylation | KAQGPAASAEEPKPV CCCCCCCCCCCCCCC | 38.02 | 25159151 | |
210 | Ubiquitination | AASAEEPKPVEAPAA CCCCCCCCCCCCCCC | 66.04 | 23503661 | |
210 | Acetylation | AASAEEPKPVEAPAA CCCCCCCCCCCCCCC | 66.04 | 26051181 | |
219 | Phosphorylation | VEAPAANSDQTVTVK CCCCCCCCCCCEEEC | 26.77 | 9310187 | |
222 | Phosphorylation | PAANSDQTVTVKE-- CCCCCCCCEEECC-- | 24.12 | 22167270 | |
224 | Phosphorylation | ANSDQTVTVKE---- CCCCCCEEECC---- | 29.28 | 23663014 | |
226 | Ubiquitination | SDQTVTVKE------ CCCCEEECC------ | 48.63 | 21963094 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BASP1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BASP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BASP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
U5S1_HUMAN | EFTUD2 | physical | 22939629 | |
GRP78_HUMAN | HSPA5 | physical | 22939629 | |
QOR_HUMAN | CRYZ | physical | 22863883 | |
HMGN5_HUMAN | HMGN5 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-31; THR-36; SER-164;SER-170; SER-172; SER-176; THR-196 AND SER-205, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-36; SER-164 AND THR-196,AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-196, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-196, AND MASSSPECTROMETRY. |